This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Candela Corporation. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Gary Varshavsky: Inventor of Tissue-Treatment Technologies
Introduction
Gary Varshavsky is an inventor based in Natick, Massachusetts, whose work focuses on medical treatment apparatus and methods for treating tissue. He is associated with Candela Corporation and holds 2 patents.
Latest Patents
Varshavsky’s listed patents address needle-based tissue treatment and the apparatus used to deliver it.
“Method of Treating Tissue” describes a method and apparatus in which a handpiece containing a cartridge of motor-driven needles is placed against tissue. The needles are driven into the treatment process, and energy is applied to them. The system measures tissue impedance at the beginning and end of treatment. If the ending impedance is higher than the starting impedance, the operator is notified that corrective action may be needed, as the needles may not have been inserted into the tissue.
“Treatment Apparatus” describes a handpiece with a motorized subsystem and rotating output shaft. An axial cam converts the shaft’s rotation into linear movement of a push rod. A removable cartridge contains a needle assembly and a piston that the push rod drives forward, while a biasing member urges the piston rearward.
Career Highlights
Varshavsky’s listed inventions combine mechanical components, such as motor-driven needles and cam-driven motion, with treatment monitoring through tissue-impedance measurements. His work is associated with Candela Corporation.
Collaborations
The provided information identifies Dmitry Gregoriev and Nicolle Dest as Varshavsky’s coworkers.
Conclusion
Gary Varshavsky’s patents describe complementary approaches to tissue treatment, pairing a motorized needle apparatus with impedance-based monitoring to support treatment delivery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
